Loading…

Low-Volume Resuscitation for Severe Intraoperative Hemorrhage: A Step in the Right Direction

The impact on outcomes resulting from crystalloids used with hemostatic close ratio resuscitation (HCRR) in intraoperative hemorrhage (IOH) has not been analyzed. We hypothesize a survival advantage in patients with IOH managed with a low-volume resuscitation (LVR) protocol during HCRR. A 4-year cas...

Full description

Saved in:
Bibliographic Details
Published in:The American surgeon 2012-09, Vol.78 (9), p.936-941
Main Authors: DUCHESNE, Juan C, GUIDRY, Chrissy, HOFFMAN, Jordan R. H, PARK, Timothy S, BOCK, Jiselle, LAWSON, Sarah, MEADE, Peter, MCSWAIN, Norman E
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3201-f7d2361ef8f3da3639c0c9e894711f985af6484505a6861e282b334c8fc3b50e3
cites cdi_FETCH-LOGICAL-c3201-f7d2361ef8f3da3639c0c9e894711f985af6484505a6861e282b334c8fc3b50e3
container_end_page 941
container_issue 9
container_start_page 936
container_title The American surgeon
container_volume 78
creator DUCHESNE, Juan C
GUIDRY, Chrissy
HOFFMAN, Jordan R. H
PARK, Timothy S
BOCK, Jiselle
LAWSON, Sarah
MEADE, Peter
MCSWAIN, Norman E
description The impact on outcomes resulting from crystalloids used with hemostatic close ratio resuscitation (HCRR) in intraoperative hemorrhage (IOH) has not been analyzed. We hypothesize a survival advantage in patients with IOH managed with a low-volume resuscitation (LVR) protocol during HCRR. A 4-year case-control study was conducted to determine the impact on mortality of LVR versus conventional resuscitation efforts (CRE) during HCRR. A total of 45 patients managed with a HCRR + LVR protocol (combination Hextend® and 3% hypertonic saline) and 55 historical cohorts managed with HCRR + CRE (lactated Ringer's) were included. Patient demographics, number of intraoperative units of packed red blood cells (PRBCs) and fresh-frozen plasma (FFP) received, and FFP:PRBC ratio were similar between groups. The mean intraoperative fluid volume was 0.76 L in the HCRR + LVR group versus 4.7 L in the HCRR + CRE group (P = 0.003). In a linear regression model HCRR + LVR versus HCRR + CRE, mean trauma intensive care unit length of stay was 6 versus 11 days (P = 0.009); 30-day overall mortality was 11.1 versus 32.7 per cent (P = 0.009); perioperative mortality was 2.2 to 10.9 per cent (P = 0.13); and intensive care unit mortality 8.8 to 21.8 per cent (P = 0.07). LVR protocol conveyed a survival benefit to patients undergoing HCRR (odds ratio for mortality, 0.07 [95% confidence interval 0.07-0.54]). This is the first civilian study to analyze the impact of LVR in patients managed with HCRR during IOH. Patients with IOH managed with HCRR and a predefined LVR protocol with Hextend® and 3 per cent hypertonic saline had an overall survival advantage and shorter trauma intensive care unit length of stay. LVR can be an effective alternative to CRE when used in combination with HCRR in patients with IOH.
doi_str_mv 10.1177/000313481207800931
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1039205401</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1039205401</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3201-f7d2361ef8f3da3639c0c9e894711f985af6484505a6861e282b334c8fc3b50e3</originalsourceid><addsrcrecordid>eNpl0F1LHDEUBuBQKnW1_QO9kEAp9GbqSTLJJL0TWz9gQeiqV8KQzZ64IzOTNZlR_PfNuquCvQqHPOfl8BLylcFPxqrqEAAEE6VmHCoNYAT7QCZMSlkYzcVHMlmDYi12yV5Kd3kslWSfyC7nRpUcYEJupuGxuA7t2CH9i2lMrhns0ISe-hDpDB8wIj3vh2jDCmP-eUB6hl2IcWlv8Rc9orMBV7Tp6bDMCc3tcqC_m4hunfGZ7HjbJvyyfffJ1cmfy-OzYnpxen58NC2c4MAKXy24UAy99mJhhRLGgTOoTVkx5o2W1qtSlxKkVTo7rvlciNJp78RcAop98mOTu4rhfsQ01F2THLat7TGMqWYgDAdZAsv02zt6F8bY5-uelTKKCciKb5SLIaWIvl7FprPxKaN63X39f_d56WAbPc47XLyuvJSdwfctsMnZ1kfbuya9OcWNqSQT_wAagokp</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1039696130</pqid></control><display><type>article</type><title>Low-Volume Resuscitation for Severe Intraoperative Hemorrhage: A Step in the Right Direction</title><source>Sage Journals Online</source><creator>DUCHESNE, Juan C ; GUIDRY, Chrissy ; HOFFMAN, Jordan R. H ; PARK, Timothy S ; BOCK, Jiselle ; LAWSON, Sarah ; MEADE, Peter ; MCSWAIN, Norman E</creator><creatorcontrib>DUCHESNE, Juan C ; GUIDRY, Chrissy ; HOFFMAN, Jordan R. H ; PARK, Timothy S ; BOCK, Jiselle ; LAWSON, Sarah ; MEADE, Peter ; MCSWAIN, Norman E</creatorcontrib><description>The impact on outcomes resulting from crystalloids used with hemostatic close ratio resuscitation (HCRR) in intraoperative hemorrhage (IOH) has not been analyzed. We hypothesize a survival advantage in patients with IOH managed with a low-volume resuscitation (LVR) protocol during HCRR. A 4-year case-control study was conducted to determine the impact on mortality of LVR versus conventional resuscitation efforts (CRE) during HCRR. A total of 45 patients managed with a HCRR + LVR protocol (combination Hextend® and 3% hypertonic saline) and 55 historical cohorts managed with HCRR + CRE (lactated Ringer's) were included. Patient demographics, number of intraoperative units of packed red blood cells (PRBCs) and fresh-frozen plasma (FFP) received, and FFP:PRBC ratio were similar between groups. The mean intraoperative fluid volume was 0.76 L in the HCRR + LVR group versus 4.7 L in the HCRR + CRE group (P = 0.003). In a linear regression model HCRR + LVR versus HCRR + CRE, mean trauma intensive care unit length of stay was 6 versus 11 days (P = 0.009); 30-day overall mortality was 11.1 versus 32.7 per cent (P = 0.009); perioperative mortality was 2.2 to 10.9 per cent (P = 0.13); and intensive care unit mortality 8.8 to 21.8 per cent (P = 0.07). LVR protocol conveyed a survival benefit to patients undergoing HCRR (odds ratio for mortality, 0.07 [95% confidence interval 0.07-0.54]). This is the first civilian study to analyze the impact of LVR in patients managed with HCRR during IOH. Patients with IOH managed with HCRR and a predefined LVR protocol with Hextend® and 3 per cent hypertonic saline had an overall survival advantage and shorter trauma intensive care unit length of stay. LVR can be an effective alternative to CRE when used in combination with HCRR in patients with IOH.</description><identifier>ISSN: 0003-1348</identifier><identifier>EISSN: 1555-9823</identifier><identifier>DOI: 10.1177/000313481207800931</identifier><identifier>PMID: 22964200</identifier><identifier>CODEN: AMSUAW</identifier><language>eng</language><publisher>Atlanta, GA: Southeastern Surgical Congress</publisher><subject><![CDATA[Biological and medical sciences ; Blood banks ; Blood Loss, Surgical - mortality ; Blood Loss, Surgical - prevention & control ; Case-Control Studies ; Erythrocyte Transfusion ; Female ; Fluid Therapy - methods ; General aspects ; Hemodynamics - physiology ; Hemorrhage - mortality ; Hemorrhage - prevention & control ; Hemostatic Techniques ; Hospitals ; Humans ; Hydroxyethyl Starch Derivatives - administration & dosage ; Intensive care ; Intensive Care Units - statistics & numerical data ; Isotonic Solutions - administration & dosage ; Length of Stay - statistics & numerical data ; Linear Models ; Male ; Medical sciences ; Middle Aged ; Mortality ; Plasma ; Plasma Substitutes - administration & dosage ; Respiratory distress syndrome ; Resuscitation - methods ; Saline Solution, Hypertonic - administration & dosage ; Survival Analysis ; Treatment Outcome]]></subject><ispartof>The American surgeon, 2012-09, Vol.78 (9), p.936-941</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright Southeastern Surgical Congress Sep 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3201-f7d2361ef8f3da3639c0c9e894711f985af6484505a6861e282b334c8fc3b50e3</citedby><cites>FETCH-LOGICAL-c3201-f7d2361ef8f3da3639c0c9e894711f985af6484505a6861e282b334c8fc3b50e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26299751$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22964200$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DUCHESNE, Juan C</creatorcontrib><creatorcontrib>GUIDRY, Chrissy</creatorcontrib><creatorcontrib>HOFFMAN, Jordan R. H</creatorcontrib><creatorcontrib>PARK, Timothy S</creatorcontrib><creatorcontrib>BOCK, Jiselle</creatorcontrib><creatorcontrib>LAWSON, Sarah</creatorcontrib><creatorcontrib>MEADE, Peter</creatorcontrib><creatorcontrib>MCSWAIN, Norman E</creatorcontrib><title>Low-Volume Resuscitation for Severe Intraoperative Hemorrhage: A Step in the Right Direction</title><title>The American surgeon</title><addtitle>Am Surg</addtitle><description>The impact on outcomes resulting from crystalloids used with hemostatic close ratio resuscitation (HCRR) in intraoperative hemorrhage (IOH) has not been analyzed. We hypothesize a survival advantage in patients with IOH managed with a low-volume resuscitation (LVR) protocol during HCRR. A 4-year case-control study was conducted to determine the impact on mortality of LVR versus conventional resuscitation efforts (CRE) during HCRR. A total of 45 patients managed with a HCRR + LVR protocol (combination Hextend® and 3% hypertonic saline) and 55 historical cohorts managed with HCRR + CRE (lactated Ringer's) were included. Patient demographics, number of intraoperative units of packed red blood cells (PRBCs) and fresh-frozen plasma (FFP) received, and FFP:PRBC ratio were similar between groups. The mean intraoperative fluid volume was 0.76 L in the HCRR + LVR group versus 4.7 L in the HCRR + CRE group (P = 0.003). In a linear regression model HCRR + LVR versus HCRR + CRE, mean trauma intensive care unit length of stay was 6 versus 11 days (P = 0.009); 30-day overall mortality was 11.1 versus 32.7 per cent (P = 0.009); perioperative mortality was 2.2 to 10.9 per cent (P = 0.13); and intensive care unit mortality 8.8 to 21.8 per cent (P = 0.07). LVR protocol conveyed a survival benefit to patients undergoing HCRR (odds ratio for mortality, 0.07 [95% confidence interval 0.07-0.54]). This is the first civilian study to analyze the impact of LVR in patients managed with HCRR during IOH. Patients with IOH managed with HCRR and a predefined LVR protocol with Hextend® and 3 per cent hypertonic saline had an overall survival advantage and shorter trauma intensive care unit length of stay. LVR can be an effective alternative to CRE when used in combination with HCRR in patients with IOH.</description><subject>Biological and medical sciences</subject><subject>Blood banks</subject><subject>Blood Loss, Surgical - mortality</subject><subject>Blood Loss, Surgical - prevention &amp; control</subject><subject>Case-Control Studies</subject><subject>Erythrocyte Transfusion</subject><subject>Female</subject><subject>Fluid Therapy - methods</subject><subject>General aspects</subject><subject>Hemodynamics - physiology</subject><subject>Hemorrhage - mortality</subject><subject>Hemorrhage - prevention &amp; control</subject><subject>Hemostatic Techniques</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hydroxyethyl Starch Derivatives - administration &amp; dosage</subject><subject>Intensive care</subject><subject>Intensive Care Units - statistics &amp; numerical data</subject><subject>Isotonic Solutions - administration &amp; dosage</subject><subject>Length of Stay - statistics &amp; numerical data</subject><subject>Linear Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Plasma</subject><subject>Plasma Substitutes - administration &amp; dosage</subject><subject>Respiratory distress syndrome</subject><subject>Resuscitation - methods</subject><subject>Saline Solution, Hypertonic - administration &amp; dosage</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><issn>0003-1348</issn><issn>1555-9823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpl0F1LHDEUBuBQKnW1_QO9kEAp9GbqSTLJJL0TWz9gQeiqV8KQzZ64IzOTNZlR_PfNuquCvQqHPOfl8BLylcFPxqrqEAAEE6VmHCoNYAT7QCZMSlkYzcVHMlmDYi12yV5Kd3kslWSfyC7nRpUcYEJupuGxuA7t2CH9i2lMrhns0ISe-hDpDB8wIj3vh2jDCmP-eUB6hl2IcWlv8Rc9orMBV7Tp6bDMCc3tcqC_m4hunfGZ7HjbJvyyfffJ1cmfy-OzYnpxen58NC2c4MAKXy24UAy99mJhhRLGgTOoTVkx5o2W1qtSlxKkVTo7rvlciNJp78RcAop98mOTu4rhfsQ01F2THLat7TGMqWYgDAdZAsv02zt6F8bY5-uelTKKCciKb5SLIaWIvl7FprPxKaN63X39f_d56WAbPc47XLyuvJSdwfctsMnZ1kfbuya9OcWNqSQT_wAagokp</recordid><startdate>201209</startdate><enddate>201209</enddate><creator>DUCHESNE, Juan C</creator><creator>GUIDRY, Chrissy</creator><creator>HOFFMAN, Jordan R. H</creator><creator>PARK, Timothy S</creator><creator>BOCK, Jiselle</creator><creator>LAWSON, Sarah</creator><creator>MEADE, Peter</creator><creator>MCSWAIN, Norman E</creator><general>Southeastern Surgical Congress</general><general>SAGE PUBLICATIONS, INC</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7QL</scope><scope>7RV</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>201209</creationdate><title>Low-Volume Resuscitation for Severe Intraoperative Hemorrhage: A Step in the Right Direction</title><author>DUCHESNE, Juan C ; GUIDRY, Chrissy ; HOFFMAN, Jordan R. H ; PARK, Timothy S ; BOCK, Jiselle ; LAWSON, Sarah ; MEADE, Peter ; MCSWAIN, Norman E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3201-f7d2361ef8f3da3639c0c9e894711f985af6484505a6861e282b334c8fc3b50e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Biological and medical sciences</topic><topic>Blood banks</topic><topic>Blood Loss, Surgical - mortality</topic><topic>Blood Loss, Surgical - prevention &amp; control</topic><topic>Case-Control Studies</topic><topic>Erythrocyte Transfusion</topic><topic>Female</topic><topic>Fluid Therapy - methods</topic><topic>General aspects</topic><topic>Hemodynamics - physiology</topic><topic>Hemorrhage - mortality</topic><topic>Hemorrhage - prevention &amp; control</topic><topic>Hemostatic Techniques</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hydroxyethyl Starch Derivatives - administration &amp; dosage</topic><topic>Intensive care</topic><topic>Intensive Care Units - statistics &amp; numerical data</topic><topic>Isotonic Solutions - administration &amp; dosage</topic><topic>Length of Stay - statistics &amp; numerical data</topic><topic>Linear Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Plasma</topic><topic>Plasma Substitutes - administration &amp; dosage</topic><topic>Respiratory distress syndrome</topic><topic>Resuscitation - methods</topic><topic>Saline Solution, Hypertonic - administration &amp; dosage</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DUCHESNE, Juan C</creatorcontrib><creatorcontrib>GUIDRY, Chrissy</creatorcontrib><creatorcontrib>HOFFMAN, Jordan R. H</creatorcontrib><creatorcontrib>PARK, Timothy S</creatorcontrib><creatorcontrib>BOCK, Jiselle</creatorcontrib><creatorcontrib>LAWSON, Sarah</creatorcontrib><creatorcontrib>MEADE, Peter</creatorcontrib><creatorcontrib>MCSWAIN, Norman E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Family Health Database (Proquest)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The American surgeon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DUCHESNE, Juan C</au><au>GUIDRY, Chrissy</au><au>HOFFMAN, Jordan R. H</au><au>PARK, Timothy S</au><au>BOCK, Jiselle</au><au>LAWSON, Sarah</au><au>MEADE, Peter</au><au>MCSWAIN, Norman E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low-Volume Resuscitation for Severe Intraoperative Hemorrhage: A Step in the Right Direction</atitle><jtitle>The American surgeon</jtitle><addtitle>Am Surg</addtitle><date>2012-09</date><risdate>2012</risdate><volume>78</volume><issue>9</issue><spage>936</spage><epage>941</epage><pages>936-941</pages><issn>0003-1348</issn><eissn>1555-9823</eissn><coden>AMSUAW</coden><abstract>The impact on outcomes resulting from crystalloids used with hemostatic close ratio resuscitation (HCRR) in intraoperative hemorrhage (IOH) has not been analyzed. We hypothesize a survival advantage in patients with IOH managed with a low-volume resuscitation (LVR) protocol during HCRR. A 4-year case-control study was conducted to determine the impact on mortality of LVR versus conventional resuscitation efforts (CRE) during HCRR. A total of 45 patients managed with a HCRR + LVR protocol (combination Hextend® and 3% hypertonic saline) and 55 historical cohorts managed with HCRR + CRE (lactated Ringer's) were included. Patient demographics, number of intraoperative units of packed red blood cells (PRBCs) and fresh-frozen plasma (FFP) received, and FFP:PRBC ratio were similar between groups. The mean intraoperative fluid volume was 0.76 L in the HCRR + LVR group versus 4.7 L in the HCRR + CRE group (P = 0.003). In a linear regression model HCRR + LVR versus HCRR + CRE, mean trauma intensive care unit length of stay was 6 versus 11 days (P = 0.009); 30-day overall mortality was 11.1 versus 32.7 per cent (P = 0.009); perioperative mortality was 2.2 to 10.9 per cent (P = 0.13); and intensive care unit mortality 8.8 to 21.8 per cent (P = 0.07). LVR protocol conveyed a survival benefit to patients undergoing HCRR (odds ratio for mortality, 0.07 [95% confidence interval 0.07-0.54]). This is the first civilian study to analyze the impact of LVR in patients managed with HCRR during IOH. Patients with IOH managed with HCRR and a predefined LVR protocol with Hextend® and 3 per cent hypertonic saline had an overall survival advantage and shorter trauma intensive care unit length of stay. LVR can be an effective alternative to CRE when used in combination with HCRR in patients with IOH.</abstract><cop>Atlanta, GA</cop><pub>Southeastern Surgical Congress</pub><pmid>22964200</pmid><doi>10.1177/000313481207800931</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-1348
ispartof The American surgeon, 2012-09, Vol.78 (9), p.936-941
issn 0003-1348
1555-9823
language eng
recordid cdi_proquest_miscellaneous_1039205401
source Sage Journals Online
subjects Biological and medical sciences
Blood banks
Blood Loss, Surgical - mortality
Blood Loss, Surgical - prevention & control
Case-Control Studies
Erythrocyte Transfusion
Female
Fluid Therapy - methods
General aspects
Hemodynamics - physiology
Hemorrhage - mortality
Hemorrhage - prevention & control
Hemostatic Techniques
Hospitals
Humans
Hydroxyethyl Starch Derivatives - administration & dosage
Intensive care
Intensive Care Units - statistics & numerical data
Isotonic Solutions - administration & dosage
Length of Stay - statistics & numerical data
Linear Models
Male
Medical sciences
Middle Aged
Mortality
Plasma
Plasma Substitutes - administration & dosage
Respiratory distress syndrome
Resuscitation - methods
Saline Solution, Hypertonic - administration & dosage
Survival Analysis
Treatment Outcome
title Low-Volume Resuscitation for Severe Intraoperative Hemorrhage: A Step in the Right Direction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T17%3A51%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low-Volume%20Resuscitation%20for%20Severe%20Intraoperative%20Hemorrhage:%20A%20Step%20in%20the%20Right%20Direction&rft.jtitle=The%20American%20surgeon&rft.au=DUCHESNE,%20Juan%20C&rft.date=2012-09&rft.volume=78&rft.issue=9&rft.spage=936&rft.epage=941&rft.pages=936-941&rft.issn=0003-1348&rft.eissn=1555-9823&rft.coden=AMSUAW&rft_id=info:doi/10.1177/000313481207800931&rft_dat=%3Cproquest_cross%3E1039205401%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3201-f7d2361ef8f3da3639c0c9e894711f985af6484505a6861e282b334c8fc3b50e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1039696130&rft_id=info:pmid/22964200&rfr_iscdi=true